The Dubousset Functional Test: a reliable and valid test in early stage Parkinson's disease patients.

Autor: Abit Kocaman A; Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Kırıkkale University, Kırıkkale, Turkey. ayseabit@gmail.com., Aydoğan Arslan S; Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Kırıkkale University, Kırıkkale, Turkey., Bozkurt YE; Samsun Physical Medicine and Rehabilitation Diseases Hospital, Samsun, Turkey., Coşkun E; Department of Physical Medicine and Rehabilitation, Sincan Medical Center, Ankara, Turkey.
Jazyk: angličtina
Zdroj: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Jul; Vol. 45 (7), pp. 3137-3146. Date of Electronic Publication: 2024 Feb 01.
DOI: 10.1007/s10072-024-07359-1
Abstrakt: Introduction: Dubousset Functional Test (DFT) is an assessment test evaluating the functional capacity and dynamic balance. The study aimed to examine the reliability, validity, and responsiveness of the DFT in early stage Parkinson's disease (PD) patients.
Methods: This was a cross-sectional study. Thirty-three early stage PD patients were recruited. The DFT was performed along with the Timed Up and Go (TUG) test, dual-task TUG, Functional Reach Test (FRT), 3-m backward walk test (3MBWT), Tinetti Performance-Oriented Mobility Assessment (POMA), and Berg Balance Scale (BBS).
Results: The test-retest reliability of the subcomponents of the DFT was excellent. The ICCs were as follows: 0.952, 0.955, 0.917, and 0.919, respectively. The correlation with subcomponents of DFT and TUG, dual-task TUG, FRT, 3MBWT, BBS, and POMA was found to be statistically significant (p < 0.05). The standard measurement errors of the subcomponents of the DFT were 1.45, 1.39, 1.70, and 1.57, respectively. The minimal clinically important difference (MCID) of the subcomponents was 2.05, 1.97, 2.41, and 2.22, respectively.
Conclusion: The DFT is a reliable, valid, and easy-to-administer tool in assessing the balance and physical function of early stage PD patients.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: